Equitable Trust’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $919K | Buy |
32,738
+5,181
| +19% | +$138K | 0.04% | 241 |
|
|
2025
Q4 | $686K | Sell |
27,557
-1,554
| -5% | -$39.2K | 0.03% | 279 |
|
|
2025
Q3 | $742K | Hold |
29,111
| – | – | 0.03% | 277 |
|
|
2025
Q2 | $706K | Sell |
29,111
-18,330
| -39% | -$427K | 0.04% | 273 |
|
|
2025
Q1 | $1.2M | Sell |
47,441
-2,684
| -5% | -$70.2K | 0.07% | 199 |
|
|
2024
Q4 | $1.33M | Sell |
50,125
-620
| -1% | -$16.8K | 0.07% | 186 |
|
|
2024
Q3 | $1.47M | Buy |
50,745
+2,242
| +5% | +$65.4K | 0.09% | 162 |
|
|
2024
Q2 | $1.36M | Sell |
48,503
-2,535
| -5% | -$69.8K | 0.09% | 154 |
|
|
2024
Q1 | $1.42M | Buy |
51,038
+19,255
| +61% | +$534K | 0.1% | 155 |
|
|
2023
Q4 | $915K | Sell |
31,783
-7,825
| -20% | -$237K | 0.07% | 186 |
|
|
2023
Q3 | $1.31M | Sell |
39,608
-2,884
| -7% | -$102K | 0.11% | 145 |
|
|
2023
Q2 | $1.56M | Sell |
42,492
-8,282
| -16% | -$322K | 0.12% | 131 |
|
|
2023
Q1 | $2.07M | Sell |
50,774
-14,179
| -22% | -$612K | 0.16% | 116 |
|
|
2022
Q4 | $3.33M | Buy |
64,953
+1,876
| +3% | +$89.9K | 0.26% | 80 |
|
|
2022
Q3 | $2.76M | Buy |
63,077
+1,737
| +3% | +$84.4K | 0.23% | 96 |
|
|
2022
Q2 | $3.22M | Buy |
61,340
+4,803
| +8% | +$245K | 0.24% | 88 |
|
|
2022
Q1 | $2.93M | Buy |
56,537
+2,179
| +4% | +$113K | 0.19% | 107 |
|
|
2021
Q4 | $3.21M | Buy |
54,358
+5,694
| +12% | +$282K | 0.2% | 105 |
|
|
2021
Q3 | $2.09M | Sell |
48,664
-320
| -0.7% | -$14.2K | 0.13% | 131 |
|
|
2021
Q2 | $1.92M | Sell |
48,984
-33,027
| -40% | -$1.28M | 0.12% | 136 |
|
|
2021
Q1 | $2.97M | Buy |
82,011
+2,182
| +3% | +$77.5K | 0.22% | 106 |
|
|
2020
Q4 | $2.94M | Sell |
79,829
-47
| -0.1% | -$1.72K | 0.22% | 111 |
|
|
2020
Q3 | $2.78M | Sell |
79,876
-241
| -0.3% | -$8.45K | 0.24% | 107 |
|
|
2020
Q2 | $2.48M | Buy |
80,117
+1,245
| +2% | +$42.3K | 0.23% | 103 |
|
|
2020
Q1 | $2.44M | Buy |
78,872
+11,032
| +16% | +$376K | 0.27% | 98 |
|
|
2019
Q4 | $2.52M | Sell |
67,840
-25,907
| -28% | -$923K | 0.25% | 99 |
|
|
2019
Q3 | $3.2M | Sell |
93,747
-1,503
| -2% | -$54.7K | 0.34% | 76 |
|
|
2019
Q2 | $3.92M | Buy |
95,250
+240
| +0.3% | +$9.53K | 0.42% | 70 |
|
|
2019
Q1 | $3.83M | Buy |
95,010
+314
| +0.3% | +$12.6K | 0.44% | 70 |
|
|
2018
Q4 | $3.92M | Buy |
94,696
+10,758
| +13% | +$447K | 0.52% | 59 |
|
|
2018
Q3 | $3.51M | Buy |
83,938
+419
| +0.5% | +$16.1K | 0.41% | 73 |
|
|
2018
Q2 | $2.88M | Buy |
+83,519
| New | +$2.85M | 0.36% | 83 |
|
Other funds holding PFE
VCM
VPM
Equitable Trust's PFE Position: Q1 2026 in Review
Equitable Trust increased its Pfizer (PFE) stake by 19% in Q1 2026, buying an estimated $138K and bringing the position to 32,738 shares worth $919K. The position accounts for 0.04% of the portfolio, ranked #241.
Equitable Trust first reported a position in PFE in Q2 2018 and has held it in 32 quarters since. The position peaked at $3.92M in Q4 2018. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Equitable Trust held 32,738 shares of Pfizer worth $919K as of Q1 2026.
- Equitable Trust bought 5,181 Pfizer shares in Q1 2026, an estimated $138K.
- Pfizer made up 0.04% of Equitable Trust's portfolio in Q1 2026, its #241 holding.
- Equitable Trust first reported a position in Pfizer in Q2 2018 and has held it in 32 quarters since.
- Equitable Trust's Pfizer position peaked at $3.92M in Q4 2018.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Equitable Trust's 13F filing for Q1 2026, filed 30 Apr 2026.